In episode 12 we talk about approval of Givlaari for acute hepatic porphyria, a second approval for sickle cell disease, a new formulation of an old product for ALS, the 26th biosimlar approved in the US, and approval of Calquence for CLL & SLL. We also talk about updated recommendations on pneumococcal vaccination from the CDC (PCV13)